Torrent Pharmaceuticals (TORNTPHARM) — Financial Results

Torrent Pharmaceuticals Limited announced a post-quarterly financial results conference call scheduled for February 13, 2026, at 6:30 P.M. IST to discuss Q3 FY2026 performance (quarter ended December 31, 2025). The company provided dial-in numbers for domestic and international participants, along with a Diamond Pass registration link for investor access.

📄 View Original Announcement (PDF)

📊 Stock Analysis — TORNTPHARM ✨ Ask AI About This

About Torrent Pharmaceuticals Limited (TORNTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,49,108.91 Cr P/E: 80.1

View full TORNTPHARM stock details →

📡 Get AI alerts when TORNTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TORNTPHARM — Free

💡 Ask AI about this filing

"How does this financial results affect Torrent Pharmaceuticals Limited's outlook?" "What did Torrent Pharmaceuticals Limited announce on 2 February 2026?" "Is this positive or negative for TORNTPHARM?"

Ask AI Free →

📊 More TORNTPHARM filings

See all TORNTPHARM filings →

🔥 Also filed on 2 February 2026

CANBK Canara Bank Corporate Action VEDL Vedanta Limited Financial Results TATASTEEL Tata Steel Limited Announcement ASIANPAINT Asian Paints Limited Financial Results AXISBANK Axis Bank Limited Financial Results CHOLAFIN Cholamandalam Investment and Finance Company Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TORNTPHARM files new disclosures

Track TORNTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.